Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion type Assertion NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_head.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion description "[Moreover, treatment of WT mice with soluble ObR fusion protein (ObR:Fc) increased the percentage of T(Regs) and ameliorated the clinical course and progression of disease in proteolipid protein peptide (PLP(139-151))-induced relapsing-experimental autoimmune encephalomyelitis (R-EAE), an animal model of RRMS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_provenance.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion evidence source_evidence_literature NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_provenance.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion SIO_000772 15788534 NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_provenance.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion wasDerivedFrom befree-20150227 NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_provenance.
- NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_assertion wasGeneratedBy ECO_0000203 NP927322.RASd7CbtJzwjS5QoFocB0fvm2mfEnYZxoRSHSBI4h4-1k130_provenance.